Company · CIK 1723069
Tiziana Life Sciences Ltd
| CIK | 1723069 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | D0 |
| Business address | United Kingdom |
| Listed | TLSA (Nasdaq) |
| First annual or quarterly report | 2019-04-04 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-286064 | 2025-03-24 | 2026-01-22 | 5 | |
| 333-252441 | 2021-01-26 | 2024-11-01 | 5 | |
| 333-236013 | 2020-01-22 | 2020-08-04 | 6 | |
| 333-233020 | 2019-08-05 | 2019-10-22 | 4 | |
| 333-226368 | 2018-07-26 | 2018-11-21 | 9 |
Filings
36| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-01-22 | 424B5Shelf takedown | 333-286064 | 0001213900-26-006375 |
| 2026-01-16 | 424B5Shelf takedown | 333-286064 | 0001213900-26-004895 |
| 2025-12-12 | 424B5Shelf takedown | 333-286064 | 0001213900-25-121308 |
| 2025-03-27 | EFFECTDeclared effective | 333-286064 | 9999999995-25-000820 |
| 2025-03-24 | F-3Shelf registered | 333-286064 | 0001013762-25-001691 |
| 2024-11-01 | 424B5Shelf takedown | 333-252441 | 0001213900-24-093087 |
| 2024-10-25 | 424B5Shelf takedown | 333-252441 | 0001213900-24-090848 |
| 2023-09-01 | 424B5Shelf takedown | 333-252441 | 0001213900-23-073332 |
| 2022-03-03 | EFFECTDeclared effective | 333-252441 | 9999999995-22-000548 |
| 2021-01-26 | F-3Shelf registered | 333-252441 | 0001213900-21-004453 |
| 2020-08-04 | 424B5Shelf takedown | 333-236013 | 0001213900-20-020182 |
| 2020-04-10 | 424B5Shelf takedown | 333-236013 | 0001213900-20-009004 |
| 2020-03-13 | 424B5Shelf takedown | 333-236013 | 0001213900-20-006237 |
| 2020-02-14 | 424B5Shelf takedown | 333-236013 | 0001213900-20-003950 |
| 2020-02-06 | EFFECTDeclared effective | 333-236013 | 9999999995-20-000277 |
| 2020-01-22 | F-3Shelf registered | 333-236013 | 0001213900-20-001553 |
| 2019-10-22 | RWWithdrawn | 333-233020 | 0001213900-19-020789 |
| 2019-09-20 | F-1/AAmendment | 333-233020 | 0001213900-19-018544 |
| 2019-09-17 | F-1/AAmendment | 333-233020 | 0001213900-19-018314 |
| 2019-08-05 | F-1Registration filed | 333-233020 | 0001213900-19-014612 |
| 2019-07-17 | DRSDraft made public | 377-02736 | 0001213900-19-012921 |
| 2018-11-21 | 424B4Final prospectus | 333-226368 | 0001213900-18-016357 |
| 2018-11-19 | EFFECTDeclared effective | 333-226368 | 9999999995-18-002925 |
| 2018-11-09 | EFFECTDeclared effective | 333-227509 | 9999999995-18-002853 |
| 2018-11-09 | EFFECTDeclared effective | 333-226368 | 9999999995-18-002847 |
| 2018-10-30 | F-1/AAmendment | 333-226368 | 0001213900-18-014617 |
| 2018-10-23 | F-1/AAmendment | 333-226368 | 0001213900-18-014269 |
| 2018-10-18 | F-1/AAmendment | 333-226368 | 0001213900-18-014062 |
| 2018-09-25 | F-1/AAmendment | 333-226368 | 0001213900-18-012939 |
| 2018-08-23 | F-1/AAmendment | 333-226368 | 0001213900-18-011631 |
| 2018-07-26 | F-1Registration filed | 333-226368 | 0001213900-18-009705 |
| 2018-02-27 | DRSDraft made public | 377-01952 | 0001208646-18-000023 |
| 2018-02-09 | DRSDraft made public | 377-01923 | 0001208646-18-000016 |
| 2018-02-08 | DRSDraft made public | 377-01919 | 0001208646-18-000012 |
| 2017-12-22 | DRSDraft made public | 377-01856 | 0001208646-17-000098 |
| 2017-11-30 | DRSDraft made public | 377-01809 | 0001208646-17-000093 |